540395 — Chemcrux Enterprises Income Statement

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMicro CapFalling Star

Annual income statement for Chemcrux Enterprises, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

	2020 March 31st	2021 March 31st	R2022 March 31st	2023 March 31st	2024 March 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	PRESS
Standards:	IAS	IAS	IAS	IAS	—
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	574	533	953	952	785
Cost of Revenue
Gross Profit	367	325	474	522	473
Selling / General / Administrative Expenses
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	438	419	762	757	675
Operating Profit	137	114	191	194	109
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	142	120	199	196	114
Provision for Income Taxes
Net Income After Taxes	106	89.3	149	144	84.4
Net Income Before Extraordinary Items
Net Income	106	89.3	149	144	84.4
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	106	89.3	149	144	84.4
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	21.6	18.1	10	9.69	5.7
Dividends per Share